Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Shen, Lei  [Clear All Filters]
2022
Zhang X-D, Sun S-L, Wang G, Li X-L, Yao L-J, Xu H, Zhang P, Shen L. [Protective effects of estrogen modified hBMSC on HG-induced injury of vascular endothelial cells]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2022;38(4):289-294.
2020
Di Bacco A, Bahlis NJ, Munshi NC, Avet-Loiseau H, Masszi T, Viterbo L, Pour L, Ganly P, Cavo M, Langer C, et al. c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma. Eur J Haematol. 2020.
Lü J, Zhao Q, Ding X, Guo Y, Li Y, Xu Z, Li S, Wang Z, Shen L, Chen H, et al. Cyclin D1 promotes secretion of pro-oncogenic immuno-miRNAs and piRNAs. Clin Sci (Lond). 2020.
2018
Chang L, Shen L, Zhou H, Gao J, Pan H, Zheng L, Armstrong B, Peng Y, Peng G, Zhou BP, et al. ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage response. Nucleic Acids Res. 2018.
2016
Zhao Q, Deng S, Wang G, Liu CC, Meng L, Qiao S, Shen L, Zhang Y, Lü J, Li W, et al. A direct quantification method for measuring plasma MicroRNAs identified potential biomarkers for detecting metastatic breast cancer. Oncotarget. 2016.
2014
He S, Shen L, Wu Y, Li L, Chen W, Hou C, Yang M, Zeng W, Zhu C. Effect of Brain-Derived Neurotrophic Factor on Mesenchymal Stem Cells -seeded electrospinning biomaterial for treating ischemic diabetic ulcers via milieu-dependent differentiation mechanism. Tissue Eng Part A. 2014.